Endoscopic Foam Sclerotherapy for Internal Hemorrhoids

Phase 4, randomised, open-label trial of polidocanol in internal hemorrhoids (2 arms), sponsored by Xinhua Hospital. Primary endpoints: Condition of bleeding, perianal pruritus, degree of prolapse, and influence of internal hemorrhoids by self-assessment at 12 months and Condition of perianal pruritus, description of hemorrhoids (number and depth), need for additional sclerotherapy at 12 months. Status: unknown.